Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation. - Galeone A; Salem JE; Lebreton G; Coutance G; Nguyen L; Hulot JS; Atassi F; Bega M; Leprince P; Varnous S (Clinical transplantation, 2022)